chitosan has been researched along with Dry Eye in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, Z; Yu, F; Zhang, AY; Zheng, M | 1 |
| Bračko, D; Crespo Moral, M; Diebold, Y; Filipović-Grčić, J; Juretić, M; Jurišić Dukovski, B; Lovrić, J; Pepić, I; Randjelović, D; Savić, S | 1 |
| Hoeller, S; Knoetzl, W; Nepp, J; Prinz, A; Prinz, M | 1 |
| Baumgartner, R; Garhöfer, G; Höller, S; Kaya, S; O'Rourke, M; Peterson, W; Prinz, M; Schmetterer, L; Schmidl, D; Unterhuber, A; Werkmeister, R; Witkowska, KJ; Wolter, A | 1 |
| Dua, HS; Messina, M | 1 |
| Gong, L; Lin, T; Lu, Y; Wei, C; Zhang, X | 1 |
| Cazarim, MS; Cruz-Cazarim, ELC; Lopez, RFV; Ogunjimi, AT; Petrilli, R; Rocha, EM | 1 |
| Chae, JJ; Chuck, RS; Hongyok, T; Li, L; Na, D; Shin, YJ | 1 |
2 trial(s) available for chitosan and Dry Eye
| Article | Year |
|---|---|
A Controlled, Randomized Double-Blind Study to Evaluate the Safety and Efficacy of Chitosan-N-Acetylcysteine for the Treatment of Dry Eye Syndrome.
Topics: Acetylcysteine; Adult; Chitosan; Cohort Studies; Double-Blind Method; Dry Eye Syndromes; Female; Humans; Male; Tears; Tomography, Optical Coherence | 2017 |
Treatment of dry eye by intracanalicular injection of a thermosensitive chitosan-based hydrogel: evaluation of biosafety and availability.
Topics: Adult; Animals; Cells, Cultured; Chitosan; Dry Eye Syndromes; Female; Humans; Hydrogels; Injections, Intraocular; Male; Middle Aged; Rabbits | 2018 |
6 other study(ies) available for chitosan and Dry Eye
| Article | Year |
|---|---|
A cerium oxide loaded glycol chitosan nano-system for the treatment of dry eye disease.
Topics: Animals; Antioxidants; Cerium; Chitosan; Conjunctiva; Cornea; Disease Models, Animal; Dry Eye Syndromes; Female; Mice; Mice, Inbred C57BL; Nanoparticles; Reactive Oxygen Species; Solubility; Superoxide Dismutase; Tears | 2019 |
Functional ibuprofen-loaded cationic nanoemulsion: Development and optimization for dry eye disease treatment.
Topics: Animals; Cations; Cell Line; Chemistry, Pharmaceutical; Chitosan; Drug Delivery Systems; Drug Stability; Dry Eye Syndromes; Emulsions; Female; Humans; Ibuprofen; Lecithins; Male; Nanoparticles; Particle Size; Solubility; Surface-Active Agents; Swine; Viscosity | 2020 |
Management of moderate-to-severe dry eye disease using chitosan-N-acetylcysteine (Lacrimera®) eye drops: a retrospective case series.
Topics: Acetylcysteine; Adult; Aged; Chitosan; Dry Eye Syndromes; Female; Follow-Up Studies; Humans; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Tears; Treatment Outcome; Young Adult | 2020 |
Early results on the use of chitosan-N-acetylcysteine (Lacrimera
Topics: Acetylcysteine; Adult; Aged; Aged, 80 and over; Chitosan; Dry Eye Syndromes; Female; Follow-Up Studies; Humans; Keratitis; Lubricant Eye Drops; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Time Factors; Treatment Outcome | 2019 |
Prospective insulin-based ophthalmic delivery systems for the treatment of dry eye syndrome and corneal injuries.
Topics: Administration, Topical; Animals; Chitosan; Cornea; Corneal Injuries; Diabetes Mellitus, Experimental; Dry Eye Syndromes; Epithelium, Corneal; Humans; Insulin; Lacrimal Apparatus; Male; Ophthalmic Solutions; Poloxamer; Prospective Studies; Rats; Rats, Wistar; Tears | 2019 |
Effect of chitosan-N-acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye.
Topics: Acetylcysteine; Administration, Topical; Animals; Blinking; Botulinum Toxins; Botulinum Toxins, Type A; Chitosan; Conjunctiva; Cornea; Cytokines; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescent Antibody Technique, Indirect; Fluorometholone; Lacrimal Apparatus; Mice; Mice, Inbred CBA; Ophthalmic Solutions; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tears | 2009 |